{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:29Z","timestamp":1792784129209,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The natural Science Foundation Project of Jiangxi Province"},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224BAB206083"],"award-info":[{"award-number":["20224BAB206083"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jbc.2025.110387","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T13:45:41Z","timestamp":1750254341000},"page":"110387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["TFAP2C drives cisplatin resistance in bladder cancer by upregulating YAP and activating \u03b2-catenin signaling"],"prefix":"10.1016","volume":"301","author":[{"given":"Qiufeng","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longwang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110387_bib1","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.3390\/cancers13194891","article-title":"Targetable pathways in advanced bladder cancer: FGFR signaling","volume":"13","author":"Xiao","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2025.110387_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jbc.2025.110387_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jbc.2025.110387_bib4","first-page":"69","article-title":"Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer","volume":"4","author":"Rajendran","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.jbc.2025.110387_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101059","article-title":"Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jbc.2025.110387_bib6","article-title":"Targeting DNA damage and repair machinery via delivering WEE1 inhibitor and platinum (IV) prodrugs to stimulate STING pathway for maximizing chemo-immunotherapy in bladder cancer","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jbc.2025.110387_bib7","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/onc.2015.219","article-title":"YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage","volume":"35","author":"Ciamporcero","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2025.110387_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.freeradbiomed.2017.12.005","article-title":"Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer","volume":"115","author":"Ciamporcero","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jbc.2025.110387_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.phymed.2018.10.034","article-title":"Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression","volume":"56","author":"Daga","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jbc.2025.110387_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41585-024-00857-z","article-title":"Targeting histone modifiers in bladder cancer therapy - preclinical and clinical evidence","volume":"21","author":"Zhang","year":"2024","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jbc.2025.110387_bib11","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/cells9081850","article-title":"DNA methylation as a therapeutic target for bladder cancer","volume":"9","author":"Nunes","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2025.110387_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13046-023-02932-6","article-title":"EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance","volume":"43","author":"Wei","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110387_bib13","article-title":"Clinical potential of the Hippo-YAP pathway in bladder cancer","volume":"12","author":"Cheng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2025.110387_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.freeradbiomed.2019.06.009","article-title":"Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells","volume":"141","author":"Cucci","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jbc.2025.110387_bib15","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1111\/jcmm.17005","article-title":"SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT\/\u03b2-catenin pathway","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell Mol Med"},{"key":"10.1016\/j.jbc.2025.110387_bib16","article-title":"Magnesium-assisted cisplatin inhibits bladder cancer cell survival by modulating Wnt\/\u03b2-catenin signaling pathway","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110387_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12916-023-03243-5","article-title":"LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated \u03b2-catenin dephosphorylation in a subset of stem-like bladder cancer cells","volume":"22","author":"Shi","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.jbc.2025.110387_bib18","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.gendis.2023.03.031","article-title":"Echinatin inhibits tumor growth and synergizes with chemotherapeutic agents against human bladder cancer cells by activating p38 and suppressing Wnt\/\u03b2-catenin pathways","volume":"11","author":"Wang","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.jbc.2025.110387_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12967-023-04189-1","article-title":"Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views","volume":"21","author":"Jin","year":"2023","journal-title":"J. Transl Med."},{"key":"10.1016\/j.jbc.2025.110387_bib20","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1080\/07391102.2020.1822918","article-title":"Designing of RNA aptamer against DNA binding domain of the glucocorticoid receptor: a response element-based in-silico approach","volume":"40","author":"Kandasamy","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jbc.2025.110387_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70009","article-title":"CRBN-PROTACs in cancer therapy: from mechanistic insights to clinical applications","volume":"104","author":"Thapa","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jbc.2025.110387_bib22","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.3390\/cancers13122957","article-title":"WWOX loses the ability to regulate oncogenic AP-2\u03b3 and synergizes with tumor suppressor AP-2\u03b1 in high-grade bladder cancer","volume":"13","author":"Ko\u0142at","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2025.110387_bib23","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.7150\/jca.86838","article-title":"Comprehensive analysis of prognostic value and immune infiltration of TFAP2 family members in bladder cancer from database and FFPE sample","volume":"14","author":"Yuan","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.jbc.2025.110387_bib24","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.3390\/cancers14194809","article-title":"TFAP2C knockdown sensitizes bladder cancer cells to cisplatin treatment via regulation of EGFR and NF-\u03baB","volume":"14","author":"Xing","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2025.110387_bib25","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/cells11091382","article-title":"Determination of WWOX function in modulating cellular pathways activated by AP-2\u03b1 and AP-2\u03b3 transcription factors in bladder cancer","volume":"11","author":"Ko\u0142at","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2025.110387_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13046-018-0683-9","article-title":"TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway","volume":"37","author":"Wang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110387_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s13046-019-1506-3","article-title":"ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity","volume":"38","author":"Zucchini","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110387_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41467-022-28319-3","article-title":"ROCK1 mechano-signaling dependency of human malignancies driven by TEAD\/YAP activation","volume":"13","author":"Esposito","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825022379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825022379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T23:20:32Z","timestamp":1756423232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825022379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0021925825022379"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110387","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TFAP2C drives cisplatin resistance in bladder cancer by upregulating YAP and activating \u03b2-catenin signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110387"}}